Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SSL Expert Dr. Bernhard Stapp Joins Board of Aledia

Published: Monday, May 27, 2013
Last Updated: Monday, May 27, 2013
Bookmark and Share
Former OSRAM general manager and CTO has played key role in industry’s evolution, will aid Aledia’s move towards industrialization.

Aledia has announced that solid-state lighting (SSL) industry veteran Dr. Bernhard Stapp has joined its board of directors.

Stapp brings more than a dozen years of executive experience in LED lighting technologies to Aledia, most recently in senior management positions at OSRAM, a global leader in SSL manufacturing and marketing.

As general manager and senior vice president of OSRAM AG’s SSL unit, Stapp was responsible for the company’s professional LED and OLED business.

Earlier, as SSL vice president and general manager at OSRAM Opto Semiconductors, he launched and managed the general-lighting LED business and oversaw launch of the world’s first OLED lighting products.

Prior to that, Stapp was vice president and CTO of the semiconductor company, where he oversaw global LED, laser and OLED R&D.

Earlier in his career, he held a variety of management positions in Siemens AG’s Corporate Technology division.

“Aledia’s mission is to bring fundamental change to the world’s lighting markets by making LED technology substantially more affordable and more versatile, with better performance and fewer limitations,” said Giorgio Anania, Aledia’s co-founder, president and CEO.

Anania continued, “Bernhard has been a key player at the heart of the global LED industry since its inception, and also has an outstanding technical background. His unique perspective on this industry’s future will be invaluable as Aledia moves into the next stage of its evolution.”

WireLED®, Aledia’s unique 3D microwire GaN-on-silicon technology, was developed at the CEA-Leti nanotech research institute in Grenoble.

It addresses the basic technical and economic challenges facing LED lighting by allowing production of LEDs on inexpensive industry-standard 200mm silicon wafers using standard semiconductor processes and tools.

“Aledia’s technology is, quite simply, a breakthrough for the entire LED sector,” said Stapp. “It can meet the industry’s critical requirement for cost-reduction, while using far simpler production processes and much less material than conventional approaches. I am very excited about the opportunity to join this team.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!